Request Sample Inquiry
Mrna Cancer Vaccines and Therapeutics Market

mRNA Cancer Vaccines and Therapeutics Market

mRNA Cancer Vaccines and Therapeutics Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

145

Base Year:

2022

Date

Mar - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1408

Segments Covered
  • By Application By Application Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
  • By End User By End User Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutes, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 54.99 Billion
Revenue 2030Revenue 2030: USD 193.14 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 17.00%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global mRNA Cancer Vaccines and Therapeutics Market - Segment Analysis
    1. Overview
    2. Global mRNA Cancer Vaccines and Therapeutics Market, 2016 - 2028 (USD Million)
    3. Global mRNA Cancer Vaccines and Therapeutics Market - by Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    4. Global mRNA Cancer Vaccines and Therapeutics Market - by End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
    5. Global mRNA Cancer Vaccines and Therapeutics Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America mRNA Cancer Vaccines and Therapeutics Market - Segment Analysis
    1. Overview
    2. North America mRNA Cancer Vaccines and Therapeutics Market, 2016 - 2028 (USD Million)
    3. North America mRNA Cancer Vaccines and Therapeutics Market, by Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    4. North America mRNA Cancer Vaccines and Therapeutics Market, by End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
    5. North America mRNA Cancer Vaccines and Therapeutics Market, by Country
      1. U.S.
        1. U.S. mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. U.S. mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      2. Canada
        1. Canada mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. Canada mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      3. Mexico
        1. Mexico mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. Mexico mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
  5. Europe mRNA Cancer Vaccines and Therapeutics Market - Segment Analysis
    1. Overview
    2. Europe mRNA Cancer Vaccines and Therapeutics Market, 2016 - 2028 (USD Million)
    3. Europe mRNA Cancer Vaccines and Therapeutics Market, by Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    4. Europe mRNA Cancer Vaccines and Therapeutics Market, by End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
    5. Europe mRNA Cancer Vaccines and Therapeutics Market, by Country
      1. Germany
        1. Germany mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. Germany mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      2. UK
        1. UK Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. UK Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      3. France
        1. France mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. France mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      4. Spain
        1. Spain mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. Spain mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      5. Italy
        1. Italy mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. Italy mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      6. BENELUX
        1. BENELUX mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. BENELUX mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      7. Rest of Europe
        1. Rest Of Europe mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. Rest Of Europe mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
  6. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market - Segment Analysis
    1. Overview
    2. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, 2016 - 2028 (USD Million)
    3. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, by Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    4. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, by End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
    5. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, by Country
      1. China
        1. China mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. China mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      2. Japan
        1. Japan mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. Japan mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      3. India
        1. India mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. India mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      4. South Korea
        1. South Korea mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. South Korea mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      5. South East Asia
        1. South East Asia mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. South East Asia mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. Rest of Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
  7. Latin America mRNA Cancer Vaccines and Therapeutics Market - Segment Analysis
    1. Overview
    2. Latin America mRNA Cancer Vaccines and Therapeutics Market, 2016 - 2028 (USD Million)
    3. Latin America mRNA Cancer Vaccines and Therapeutics Market, by Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    4. Latin America mRNA Cancer Vaccines and Therapeutics Market, by End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
    5. Latin America mRNA Cancer Vaccines and Therapeutics Market, by Country
      1. Brazil
        1. Brazil mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. Brazil mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      2. Argentina
        1. Argentina mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. Argentina mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      3. Rest of Latin America
        1. Rest of Latin America mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. Rest of Latin America mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
  8. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market - Segment Analysis
    1. Overview
    2. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, by Application
      1. By Adeno Carcinomas
      2. By Mucinous Carcinomas
      3. By Adenosquamous Carcinomas
    4. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, by End User
      1. By Hospitals & Clinics
      2. By Ambulatory Surgical Centers
      3. By Research Institutes
      4. By Others
    5. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, by Country
      1. GCC Countries
        1. GCC Countries mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. GCC Countries mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      2. South Africa
        1. South Africa mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. South Africa mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, By Application
          1. By Adeno Carcinomas
          2. By Mucinous Carcinomas
          3. By Adenosquamous Carcinomas
        2. Rest of Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, By End User
          1. By Hospitals & Clinics
          2. By Ambulatory Surgical Centers
          3. By Research Institutes
          4. By Others
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Moderna Therapeutics (US)
    2. eTheRNA (Belgium)
    3. BioNTech (Germany)
    4. CureVac (Netherlands)
    5. In-Cell-Art (France)
    6. Translate Bio (US)
    7. Tiba Biotechnology (US)
    8. Argos Therapeutics (US)
    9. Sangamo Therapeutics (US)
    10. and Ethris (Germany).
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question
  • The global mRNA Cancer Vaccines and Therapeutics valued at USD 54.99 Billion in 2022 and is expected to reach USD 193.14 Billion in 2030 growing at a CAGR of 17.00%.

  • The prominent players in the market are Moderna Therapeutics (US), eTheRNA (Belgium), BioNTech (Germany), CureVac (Netherlands), In-Cell-Art (France), Translate Bio (US), Tiba Biotechnology (US), Argos Therapeutics (US), Sangamo Therapeutics (US), and Ethris (Germany)..

  • The market is project to grow at a CAGR of 17.00% between 2023 and 2030.

  • The driving factors of the mRNA Cancer Vaccines and Therapeutics include

    • High Growth Prospects in Emerging Markets

  • North America was the leading regional segment of the mRNA Cancer Vaccines and Therapeutics in 2022.